Hyperglycemia and Acute Pancreatitis (NCT06590233) | Clinical Trial Compass
CompletedNot Applicable
Hyperglycemia and Acute Pancreatitis
4,500 participantsStarted 2013-01
Plain-language summary
The goal of this observational study is to learn about post-acute pancreatitis diabetes mellitus (PPDM-A). The main questions it aims to answer are:
1. What are the clinical characteristics of PPDM-A?
2. What are the related factors for PPDM-A?
All patients with acute pancreatitis have been given standardized treatment for the condition.
The researchers will compare the PPDM-A group with the non-PPDM-A group to find the risk factors for PPDM-A.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients with pancreatitis attending participating centers since January 2013 (patients with clinically reported AP (ICD-10:K85 or related diagnosis));
. Age between 18 and 80 years;
. Patients have undergone glucose metabolic tests at least 1 month after discharge from hospital.
Exclusion criteria
. Patients with a history of diabetes mellitus prior to the AP attack;
. Patients who underwent pancreatic surgery;
. Patients with hereditary pancreatitis and autoimmune pancreatitis;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of participants who have developed PPDM-A
Timeframe: From the AP treatment to 5 years after the end of treatment